Norman M. Gray

666 total citations
12 papers, 505 citations indexed

About

Norman M. Gray is a scholar working on Infectious Diseases, Virology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Norman M. Gray has authored 12 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Norman M. Gray's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and Hepatitis C virus research (4 papers). Norman M. Gray is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and Hepatitis C virus research (4 papers). Norman M. Gray collaborates with scholars based in United Kingdom, Germany and Slovakia. Norman M. Gray's co-authors include Ali Ryan, Peter N. Lowe, J. M. Cameron, Charles R. Penn, David Orr, Graham Hart, Richard Boehme, Richard C. Bethell, Iain P. Chessell and Sharon Bingham and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Norman M. Gray

11 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norman M. Gray United Kingdom 8 230 219 133 102 78 12 505
Alessia Petrocchi Italy 11 298 1.3× 258 1.2× 146 1.1× 92 0.9× 138 1.8× 18 561
Cristina Gardelli Italy 14 202 0.9× 239 1.1× 125 0.9× 84 0.8× 287 3.7× 26 584
Waleed A. Zalloum Jordan 15 281 1.2× 216 1.0× 164 1.2× 64 0.6× 252 3.2× 34 697
Thippeswamy Devasamudram United States 7 160 0.7× 277 1.3× 238 1.8× 63 0.6× 126 1.6× 7 562
Jiashu Xie United States 17 289 1.3× 230 1.1× 140 1.1× 120 1.2× 97 1.2× 48 658
Gerry Rhodes United States 11 106 0.5× 434 2.0× 273 2.1× 145 1.4× 87 1.1× 21 709
J. J. PLATTNER United States 10 159 0.7× 406 1.9× 293 2.2× 73 0.7× 91 1.2× 25 722
Barbara Pacini Italy 8 104 0.5× 191 0.9× 48 0.4× 110 1.1× 89 1.1× 9 330
Lanlan Jing China 13 221 1.0× 258 1.2× 206 1.5× 103 1.0× 325 4.2× 22 623
Lianhong Xu United States 18 270 1.2× 231 1.1× 146 1.1× 71 0.7× 378 4.8× 42 920

Countries citing papers authored by Norman M. Gray

Since Specialization
Citations

This map shows the geographic impact of Norman M. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman M. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman M. Gray more than expected).

Fields of papers citing papers by Norman M. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman M. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman M. Gray. The network helps show where Norman M. Gray may publish in the future.

Co-authorship network of co-authors of Norman M. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Norman M. Gray. A scholar is included among the top collaborators of Norman M. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman M. Gray. Norman M. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bingham, Sharon, Paul Beswick, David Blum, Norman M. Gray, & Iain P. Chessell. (2006). The role of the cylooxygenase pathway in nociception and pain. Seminars in Cell and Developmental Biology. 17(5). 544–554. 34 indexed citations
2.
Carroll, Anthony R., et al.. (2005). Development of Cell-Based Assays for In Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 49(4). 1381–1390. 12 indexed citations
3.
Gray, Norman M., et al.. (2003). Expression and Characterization of HCV NS3 Protease. Humana Press eBooks. 19. 343–352. 2 indexed citations
4.
Ryan, Ali, et al.. (2003). Effect of Detergent on “Promiscuous” Inhibitors. Journal of Medicinal Chemistry. 46(16). 3448–3451. 193 indexed citations
5.
Slater, Martin J., David Andrews, Berwyn Clarke, et al.. (2002). Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. Bioorganic & Medicinal Chemistry Letters. 12(23). 3359–3362. 13 indexed citations
6.
Andrews, David, et al.. (2002). Pyrrolidine-5,5-trans-lactams. 1. Synthesis and Incorporation into Inhibitors of Hepatitis C Virus NS3/4A Protease. Organic Letters. 4(25). 4475–4478. 20 indexed citations
7.
8.
Gray, Norman M., N. Cammack, Kevin N. Cobley, et al.. (1994). Discovery and Analysis of a Series of C2-Symmetric HIV-1 Proteinase Inhibitors Derived from Penicillin. Analytical Biochemistry. 216(1). 89–96.
9.
Humber, David C., Mark J. Bamford, Richard C. Bethell, et al.. (1993). A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships. Journal of Medicinal Chemistry. 36(21). 3120–3128. 15 indexed citations
10.
Hart, Graham, David Orr, Charles R. Penn, et al.. (1992). Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma. Antimicrobial Agents and Chemotherapy. 36(8). 1688–1694. 140 indexed citations
11.
Montgomery, Douglas S., Onkar Singh, Norman M. Gray, et al.. (1991). Expression of an autoprocessing cat-HIV-1 proteinase fusion protein: Purification to homogeneity of the released 99 residue proteinase. Biochemical and Biophysical Research Communications. 175(3). 784–794. 6 indexed citations
12.
Singh, Onkar, et al.. (1991). Large scale expression and purification of recombinant HIV-1 proteinase from Escherichia coli. Journal of Biotechnology. 21(1-2). 127–136. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessia Petrocchi Breakdown of academic impact, for papers by Cristina Gardelli Breakdown of academic impact, for papers by Waleed A. Zalloum Breakdown of academic impact, for papers by Thippeswamy Devasamudram Breakdown of academic impact, for papers by Jiashu Xie Breakdown of academic impact, for papers by Gerry Rhodes Breakdown of academic impact, for papers by J. J. PLATTNER Breakdown of academic impact, for papers by Barbara Pacini Breakdown of academic impact, for papers by Lanlan Jing Breakdown of academic impact, for papers by Lianhong Xu
Rankless by CCL
2026